tenofovir has been researched along with mycophenolic acid in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (33.33) | 29.6817 |
2010's | 4 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chou, KC; González-Díaz, H; Martinez de la Vega, O; Prado-Prado, FJ; Ubeira, FM; Uriarte, E | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Coull, JJ; Drusano, GL; Hossain, MM; Margolis, DM | 1 |
Awdishu, L; Joy, MS | 1 |
Chan, CC; Pagnoux, C; Wei, DW | 1 |
2 review(s) available for tenofovir and mycophenolic acid
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Role of Pharmacogenomics in Kidney Disease and Injury.
Topics: Acute Kidney Injury; Azathioprine; Calcineurin Inhibitors; Cisplatin; Cyclophosphamide; Cytochrome P-450 Enzyme System; Enzymes; Glomerulonephritis; Humans; Hydroxychloroquine; Membrane Transport Proteins; Mycophenolic Acid; Pharmacogenetics; Polymorphism, Genetic; Rituximab; Tacrolimus; Tenofovir | 2016 |
4 other study(ies) available for tenofovir and mycophenolic acid
Article | Year |
---|---|
Unified QSAR approach to antimicrobials. 4. Multi-target QSAR modeling and comparative multi-distance study of the giant components of antiviral drug-drug complex networks.
Topics: Anti-Infective Agents; Antiviral Agents; Artificial Intelligence; Computer Simulation; Drug Evaluation, Preclinical; Molecular Structure; Quantitative Structure-Activity Relationship | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Dose proportional inhibition of HIV-1 replication by mycophenolic acid and synergistic inhibition in combination with abacavir, didanosine, and tenofovir.
Topics: Adenine; Cells, Cultured; Didanosine; Dideoxynucleosides; Dose-Response Relationship, Drug; Drug Resistance; Drug Synergism; Enzyme Inhibitors; HIV-1; Humans; Leukocytes, Mononuclear; Mycophenolic Acid; Organophosphonates; Organophosphorus Compounds; Reverse Transcriptase Inhibitors; Tenofovir; Virus Replication | 2002 |
Peripheral Ulcerative Keratitis Secondary to Chronic Hepatitis B Infection.
Topics: Antiviral Agents; Corneal Ulcer; Cryoglobulinemia; Cyclophosphamide; Female; Glucocorticoids; Hepatitis B, Chronic; Humans; Immunosuppressive Agents; Middle Aged; Mycophenolic Acid; Ophthalmologic Surgical Procedures; Prednisone; Tenofovir; Vasculitis | 2017 |